
PURE Bioscience Reports Q3 Fiscal 2026 Financial Results
PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results PURE Bioscience, Inc. creator of the patented non-toxic silver dihydrogen citrate antimicrobial, reported financial results for the fiscal third quarter ended April 30, 2026. Summary of Results of Operations – Third Quarter…














